StocksA › ARCB

ArcBest Corporation (ARCB) — Earnings Call X-Ray

Our AI read all 38 of ARCB's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
C
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.8/9
evasion 3.3/9
High CandorCritic AmmunitionUnderused Fixed CostsRaising PricesMargins ContractingDemand SlowingBacklog GrowingQuestion Left Hanging

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-04-29 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of ARCB's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q4 2024 earnings call 2025-01-31 move ±11.4%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: growingPricing: raisingCapex: decreasing 12 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-11-01 move ±8%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: growingPricing: raisingHeadcount: flatCapex: decreasing 12 analysts · 21 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q2 2024 earnings call 2024-08-02 move ±11.3%

Management held guidance steady against slowing demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: slowingMargins: expandingBacklog: growingPricing: raisingHeadcount: flatCapex: flat 11 analysts · 26 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-04-30 move ±13.3%

Management gave no formal guidance against mixed demand signals. The delivery was unusually candid, rich in specifics.

Demand: mixedMargins: stableBacklog: growingPricing: raisingHeadcount: flatCapex: increasing 11 analysts · 22 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2024-02-06 move ±9.7%

Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Demand: mixedMargins: contractingPricing: raisingHeadcount: cuttingCapex: increasing 11 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q3 2023 earnings call 2023-10-27 move ±18.5%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: mixedMargins: expandingPricing: raisingHeadcount: flatCapex: decreasing 11 analysts · 25 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q2 2023 earnings call 2023-07-28 move ±11.3%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingPricing: raisingHeadcount: flatCapex: decreasing 9 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-04-28 C+ maintainedslowingcontracting 7/9 3/9
Q4 2022 2023-02-03 C maintainedslowingcontracting 6/9 4/9
Q3 2022 2022-11-01 C maintainedslowingcontracting 7/9 3/9
Q2 2022 2022-07-29 D loweredstableexpanding 5/9 4/9
Q1 2022 2022-04-29 C+ maintainedstableexpanding 6/9 3/9
Q4 2021 2022-02-01 B raisedacceleratingexpanding 7/9 4/9
Q3 2021 2021-11-02 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2021 2021-08-02 B+ raisedacceleratingexpanding 7/9 4/9
Q1 2021 2021-05-04 B maintainedacceleratingexpanding 7/9 2/9
Q4 2020 2021-02-02 B+ noneacceleratingexpanding 7/9 3/9
Q3 2020 2020-11-03 C+ noneacceleratingexpanding 7/9 3/9
Q2 2020 2020-07-29 C+ maintainedacceleratingcontracting 7/9 4/9
Q1 2020 2020-05-05 D loweredslowingcontracting 7/9 4/9
Q4 2019 2020-01-31 C maintainedslowingcontracting 7/9 4/9
Q3 2019 2019-11-01 D loweredslowingcontracting 7/9 3/9
Q2 2019 2019-08-01 C maintainedslowingcontracting 7/9 4/9
Q1 2019 2019-05-03 C+ maintainedmixedstable 7/9 2/9
Q4 2018 2019-01-31 C+ noneslowingexpanding 7/9 3/9
Q3 2018 2018-11-02 B maintainedstableexpanding 7/9 2/9
Q2 2018 2018-08-01 B maintainedacceleratingexpanding 7/9 2/9
Q1 2018 2018-05-10 C+ maintainedmixedexpanding 7/9 0/9
Q4 2017 2018-01-31 F maintainedmixedstable 6/9 7/9
Q3 2017 2017-11-03 D maintainedmixedexpanding 6/9 7/9
Q2 2017 2017-07-28 C+ raisedmixedexpanding 6/9 5/9
Q1 2017 2017-05-05 C maintainedmixedcontracting 7/9 3/9
Q4 2016 2017-02-08 C nonemixedcontracting 7/9 3/9
Q3 2016 2016-11-03 C+ maintainedmixedcontracting 7/9 2/9
Q2 2016 2016-07-29 D loweredslowingcontracting 7/9 4/9
Q1 2016 2016-04-30 C noneslowingcontracting 7/9 2/9
Q4 2015 2016-02-03 D noneslowingcontracting 7/9 5/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of ARCB's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C+ Q2 2017 earnings call 2017-07-28

1 more research questions answered NO

C Q4 2016 earnings call 2017-02-08

322 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

ARC   All “A” companies    ARCC

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.